Last Updated: June 10, 2026

CORTISONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cortisone patents expire, and what generic alternatives are available?

Cortisone is a drug marketed by Pharmacia And Upjohn, Watson Labs, Barr, Chartwell Molecular, Elkins Sinn, Everylife, Heather, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Panray, Purepac Pharm, Vitarine, and Whiteworth Town Plsn. and is included in eighteen NDAs.

The generic ingredient in CORTISONE is cortisone acetate. There are seventy-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cortisone acetate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CORTISONE?
  • What are the global sales for CORTISONE?
  • What is Average Wholesale Price for CORTISONE?
Summary for CORTISONE
US Patents:0
Applicants:15
NDAs:18
DailyMed Link:CORTISONE at DailyMed

US Patents and Regulatory Information for CORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate INJECTABLE;INJECTION 008126-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate TABLET;ORAL 008126-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Whiteworth Town Plsn CORTISONE ACETATE cortisone acetate TABLET;ORAL 080341-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Molecular CORTISONE ACETATE cortisone acetate TABLET;ORAL 080694-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs CORTISONE ACETATE cortisone acetate INJECTABLE;INJECTION 083147-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Impax Labs CORTISONE ACETATE cortisone acetate TABLET;ORAL 009458-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.